SYNCOM

Syncom Healthcare Limited has submitted the Exchange a copy of Proceedings of Annual general meeting held on September 30, 2016.

Syncom Healthcare Limited has submitted to the Exchange a copy of Notice of Annual General Meeting to be held on September 30, 2016.

Syncom Healthcare Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2016 to September 30, 2016 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 30, 2016.

Syncom Healthcare Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.

Syncom Healthcare Limited has informed the Exchange that the Company have come across SEBI order dated June 16, 2016 on the website of -SEBI in the matter of GDR issuances by certain Indian listed Companies including Syncom Healthcare Ltd. under section 11(1), 11(4) and 11B of SEBl Act, 1992 which is self- explanatory.

Syncom Healthcare Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on June 20, 2016.

Syncom Healthcare Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.

Syncom Healthcare Limited has informed the Exchange that as per the "Code of Conduct" formed under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations , 2015 , the trading window will be closed from May 21, 2016 till forty-eight hours after the date of declaration of results for Directors, KMP, Officers and Designated Employees, and their immediate relatives.

Syncom Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 14, 2016, concluded and inter-alia transacted the following business:1. It has accepted the Resignation of Mr. Ajay Shankarlal Bankda from the office of Director and Managing director of the company.2. The Company has appointed Mr. Pratik Bankda as an additional director of the Company and also as a Managing Director of the Company subject to approval by members in general meeting.3. The Company has appointed Mrs. Manju Khandelwal as an independent director of the Company.

The Exchange had sought clarification from Syncom Healthcare Limited with respect to Complaint received by the Exchange in regard to default made by Shri Ajay Shankarlal Bankda (Managing Director) under the Negotiable Instruments Act. The Company vide letter dated April 19, 2016 has provided Shri Ajay Shankarlal Bankda's response which states that the Complaints filed are borne out of disputes arising due to personal transactions; the matter is being represented by Shri Ajay Shankarlal Bankda's advocate in the relevant court. None of the matters are linked with the Company in any way and are i

Syncom Healthcare Limited has informed the Exchange that Ms. Akansha Sisodiya has resigned from the post of Company Secretary and Compliance Officer of the Company w.e.f. April 26,2016.The Company has accepted her resignation and she ceased to be the Company Secretary and Compliance Officer of the Company with effect from April 26, 2016.

Pratik Bankda, Pranav Bankda, Ajay Shankarlal Bankda, Jagdish Prasad Bagaria and Uma Devi Bagaria has submitted to the Exchange vide letter dated April 6, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has submitted to the Exchange vide letter dated April 06, 2016 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has submitted to the Exchange, vide letter dated April 05, 2016 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has submitted to the Exchange, vide letter dated March 22, 2016 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has informed the Exchange that the Company has appointed Mr. Ashok Kumar Choudhary as director of the Company with effect from February 22, 2016.

Syncom Healthcare Limited has informed the Exchange regarding Authorised Key Managerial Personnel (KMP) for the purpose of determining and disseminating materiality of an event or information.

Syncom Healthcare Limited has informed the Exchange that Outcome of Board Meeting

Syncom Healthcare Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended December 31, 2015.

Syncom Healthcare Limited has informed the Exchange that the 'Trading window' for dealing in Equity Shares of the Company shall remain closed from February 02, 2016 to February 15, 2016 (both days inclusive).

Syncom Healthcare Limited has informed the Exchange about the Notice under Rule 4 of SEBI(Procedure for holding Inquiry and imposing Penalties by Adjudicating Officer) Rules, 1995 read with Section 15-I of the Securities and Exchange Board of India Act, 1992.

Syncom Healthcare Limited has informed the Exchange regarding Determination of Materiality KMP Contact Details.

Syncom Healthcare Limited has informed the Exchange regarding appointment of Ms. Akansha Sisodiya as Company Secretary and Compliance Officer of the Company w.e.f. 14th January, 2016.

Syncom Healthcare Limited has informed the Exchange that Mr . J. C. Paliwal as Company Secretary and Compliance Officer of the Company and Mr. B S Yadav , as Director of the Company with effect from December 19 , 2015.

Syncom Healthcare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2015.

Syncom Healthcare Limited has informed the Exchange that the 'Trading window' for dealing in Equity Shares of the Company shall remain closed from November 04, 2015 to November 17, 2015 (both days inclusive). The 'Trading window' shall reopen for dealing in securities in the Equity shares of the Company from the start of the business hours on November 18, 2015.

Syncom Healthcare Limited has informed the Exchange that the Board of Directors has resolved to change the Registered Office of the Company from- 221 Vyapar Bhawan, P D Mello Road, Mumbai (M.H.)- 400009 to:502, Advent Atria, Chincholi Bunder Road, Opp. Kingston Complex,Malad (W), Mumbai- (M.H.)-400064Within the local limits of the Mumbai city, effective from October 9, 2015.

Syncom Healthcare Limited has informed the Exchange regarding the details of Voting Results along with Consolidated Scrutinizer's Report, pursuant to clause 35A of the Listing Agreement.

Syncom Healthcare Limited has submittedto the Exchange a copy of summarized proceeding of the Annual General Meeting of Members of the Company held on September 30,2015.

Syncom Healthcare Limited has informed the Exchange that the Board of Directors of the Company has appointed Mr. Venkateswarlu Mulagada, as the Chief Financial Officer of the Company with effect from September 21, 2015.Accordingly, Mr. Venkateswarlu Mulagada, ICWA has resumed his duty as the Chief Financial Officer (CFO) on September 21, 2015.

Syncom Healthcare Limited has informed the Exchange that the Company is pleased to provide members' facility to exercise their right to vote at the Annual General Meeting (AGM) by electronic means and the business may be transacted through e-Voting Services provided by Central Depository Services (India) Limited (CDSL) at the link www.evotingindia.com to its Members in respect of the business set out in Notice of AGM, wh ich will be mailed to the members within prescribed time along with the Annual Report for the financial year ended March 31, 2015 at their registered address and emailing addr

Syncom Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 23, 2015 to September 30, 2015 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 30, 2015.

Syncom Healthcare Limited has informed the Exchange regarding Honable High Court Judgment against Show Cause Notice issued by the Local Administration.

Syncom Healthcare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2015.

Syncom Healthcare Limited has informed the Exchange that the 'Trading window' for dealing in Equity Shares of the Company shall remain closed from August 04, 2015 to August 17, 2015 (both days inclusive) for the purpose of considering the un-audited Financial Result of the Company for the Quarter ended June 30, 2015 for all the Directors / Officers / Designated Employees of the Company.The 'Trading window' shall reopen for dealing in securities in the Equity shares of the Company from the start of the business hours on August 18, 2015.

Syncom Healthcare Limited has informed the Exchange that the Corporate Office of the Company has been changed and shifted to the new premises at the following address: Syncom Healthcare Limited 114-116, Trade House, 14/3, South Tukoganj, INDORE 452 001 (MP)

Syncom Healthcare Limited has submitted to the exchange the standalone & consolidated financial results along with the Auditors Report for the period ended 31-Mar-2015.

Syncom Healthcare Limited has informed the Exchange that as per the Company s Code of Conduct for Prevention of Insider Trading read with Securities Exchange Board of India (Prohibition of Insider Trading) Regulation, 1992, the 'Trading window for dealing in Equity Shares of the Company shall remain closed from May 21, 2015 to June 03, 2015 (both days inclusive) for the purpose of considering the audited Financial Result of the Company for the Quarter & year ended March 31, 2015 for all the Directors / Officers / Designated Employees of the Company. The 'Trading window shall reopen for deal

Syncom Healthcare Limited has informed the Exchange that the Board of Directors of the Company has adopted the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information Pursuant to Regulation 8(1) of the SEBI (Prohibition of Insider Trading) Regulation, 2015.

Ajay Bankda has submitted to the Exchange vide letter dated April 03, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 31-Dec-2014.

Syncom Healthcare Limited has informed the Exchange that as per the Company's Code of Conduct for Prevention of Insider Trading read with Securities Exchange Board of India (Prohibition of Insider Trading) Regulation, 1992, the 'Trading window for dealing in Equity Shares of the Company shall remain closed from February 04, 2015 to February 16, 2015 (both days inclusive) for the purpose of considering the un-audited Financial Result of the Company for the Quarter ended December 31, 2014 for all Directors / Officers / Designated Employees of the Company. The 'Trading window shall reopen fo

Pratik Bankda has submitted to the Exchange vide letter dated January 8, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.

Syncom Healthcare Limited has informed the Exchange that the meeting of the Board of Directors has been called on November 12, 2014 and approved the following businesses: a) Appointment of Mr. Bhishampal Singh Yadav as Director of the Company effective from November 12, 2014. b) Appointment of Mrs. Sunita Garg as Independent Director of the Company effective from November 12, 2014. c) Resignation of Mr. Jagdish Prasad Bagaria from the Directorship of the Company effective from November 12, 2014. d) Appointment of Mr. Tushar Patodia as Independent Director of the Company effective from Nove

Syncom Healthcare Limited has informed the Exchange that as per the Company's Code of Conduct for Prevention of Insider Trading read with Securities Exchange Board of India ( Prohibition of Insider Trading ) Regulation, 1992, the 'Trading Window' for dealing in Equity Shares of the Company shall remain closed from November 05, 2014 to November 16, 2014 (both days inclusive) for the purpose of considering the Un-audited Financial Result of the Company for the Quarter & half year ended September 30, 2014 for all Directors/Officers/Designated Employees of the Company. Further it is informed that

Syncom Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 22, 2014, for approving the resignation of :1. Shri Goviddas Pasari, Independent Director of the Company from the position of directors of the Company and,2. Shri Bharat Kumar Doshi, Independent Director of the Company from the position of directors of the Company.

Syncom Healthcare Limited has informed the Exchange that Shri Goviddas Pasari, Director and Shri Bharat Kumar Doshi, Director of the Company have been resigned from the position of directors of the Company with immediate effect. Both the Directors were independent Directors of the Company.

Syncom Healthcare Limited has submitted to the Exchange the details of voting results of the Annual General Meeting of the Company held on September 30, 2014 along with Report of Scrutinizer pursuant to clause 35A of the Listing Agreement.

Syncom Healthcare Limited has submitted to the Exchange a copy of notice of the Annual General Meeting of the Company to be held on September 30, 2014.